Matches in Wikidata for { <http://www.wikidata.org/entity/Q91823573> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q91823573 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91823573 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91823573 description "scientific article published on 09 December 2019" @default.
- Q91823573 description "wetenschappelijk artikel" @default.
- Q91823573 description "наукова стаття, опублікована 9 грудня 2019" @default.
- Q91823573 name "Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers" @default.
- Q91823573 name "Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers" @default.
- Q91823573 type Item @default.
- Q91823573 label "Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers" @default.
- Q91823573 label "Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers" @default.
- Q91823573 prefLabel "Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers" @default.
- Q91823573 prefLabel "Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers" @default.
- Q91823573 P1433 Q91823573-039C87ED-DB83-4F00-A1DB-01BF6C319323 @default.
- Q91823573 P1476 Q91823573-07BCD771-06E6-4C51-BB51-A8D782889A8E @default.
- Q91823573 P2093 Q91823573-40FE6C1C-5F5E-4C83-8AB7-28CD04108EBA @default.
- Q91823573 P2093 Q91823573-42D4CDF1-5556-4C0C-8976-42925D86A8CC @default.
- Q91823573 P2093 Q91823573-7102B403-68BC-4BDD-A70C-1F7A44C9C717 @default.
- Q91823573 P2093 Q91823573-74E35F32-B222-4A2F-8512-D0302608EDE2 @default.
- Q91823573 P2093 Q91823573-82572EE3-BFEA-429D-860C-74802B5D0FB2 @default.
- Q91823573 P2093 Q91823573-8E874557-836B-4A07-A7B2-498CC200788D @default.
- Q91823573 P2093 Q91823573-9462A970-90FC-4A08-9E25-F56B3A56A2B8 @default.
- Q91823573 P2093 Q91823573-C08AEE8E-0B9C-46D3-B1CB-CDDE2D09882A @default.
- Q91823573 P304 Q91823573-F5F09C35-D6AA-4CCE-B467-9A7F3E7620B1 @default.
- Q91823573 P31 Q91823573-569CC015-4436-46DB-BF72-81C5AAAEB695 @default.
- Q91823573 P356 Q91823573-F81C067B-E58B-43D9-AE83-494E4E26FAEF @default.
- Q91823573 P433 Q91823573-AADFF149-CBD2-45F7-B034-925034FA80AA @default.
- Q91823573 P478 Q91823573-47BF83C7-4C2E-4B3C-83FC-52D669BB8651 @default.
- Q91823573 P50 Q91823573-D5A19C62-E504-4D17-A33F-133F3542FFC9 @default.
- Q91823573 P577 Q91823573-F326AA26-9AD1-48D0-A1C4-59715A114E82 @default.
- Q91823573 P698 Q91823573-97A6B280-99DD-4FA1-818D-61D953660075 @default.
- Q91823573 P921 Q91823573-331EF3B0-A0DD-43BB-ABC1-0CB5E2168D5A @default.
- Q91823573 P932 Q91823573-19240A6E-7E1D-47CE-81CD-8EFDF8D035F1 @default.
- Q91823573 P356 1940-6207.CAPR-19-0339 @default.
- Q91823573 P698 31818850 @default.
- Q91823573 P1433 Q2665103 @default.
- Q91823573 P1476 "Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers" @default.
- Q91823573 P2093 "Altaf Mohammed" @default.
- Q91823573 P2093 "Chen S Suen" @default.
- Q91823573 P2093 "Clinton J Grubbs" @default.
- Q91823573 P2093 "Fariba L Moeinpour" @default.
- Q91823573 P2093 "Margaret M Juliana" @default.
- Q91823573 P2093 "Robert H Shoemaker" @default.
- Q91823573 P2093 "Ronald A Lubet" @default.
- Q91823573 P2093 "Shizuko Sei" @default.
- Q91823573 P304 "273-282" @default.
- Q91823573 P31 Q13442814 @default.
- Q91823573 P356 "10.1158/1940-6207.CAPR-19-0339" @default.
- Q91823573 P433 "3" @default.
- Q91823573 P478 "13" @default.
- Q91823573 P50 Q90147744 @default.
- Q91823573 P577 "2019-12-09T00:00:00Z" @default.
- Q91823573 P698 "31818850" @default.
- Q91823573 P921 Q1215575 @default.
- Q91823573 P932 "7060101" @default.